Executive at iRegene Therapeutics
Appears in 1 story
Overseeing global clinical development of NouvSight001
About 1.5 million people worldwide have retinitis pigmentosa, an inherited disease that destroys the retina's light-sensing cells and can end in blindness. The only approved treatment covers patients with a specific RPE65 gene mutation — a small fraction of the affected population.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?